Hematologic Data From the Proband and His Family
| . | Age . | Hb (g/dL) . | Erythro blastosis (%) . | MCV (fL) . | Reticulocyte Count (%) . | Basophilic Stippling . | Bone Marrow Examination . |
|---|---|---|---|---|---|---|---|
| Patient | Birth | 11.2-150 | 85 | ||||
| 3 mo | 6-151 | 14 | 64 | 84,000 | + | ||
| 7% | |||||||
| 2 yr | 9 | 50 | 500,000 | Hyperplasia | |||
| 15% | Sideroblasts-152: 46% | ||||||
| 6 yr | 9.2 | 59 | 285,000 | Hyperplasia | |||
| 8% | Sideroblasts-152: 30% | ||||||
| 19 yr | 11 | 60 | 169,000 | ||||
| 5% | |||||||
| Father | 50 yr | 14.2 | 85 | 25,000 | |||
| <0.6% | |||||||
| Mother | 49 yr | 13.9 | 80 | 37,000 | |||
| <0.6% | |||||||
| Sister | 22 yr | 13.8 | 78 | 32,000 | |||
| <0.6% |
| . | Age . | Hb (g/dL) . | Erythro blastosis (%) . | MCV (fL) . | Reticulocyte Count (%) . | Basophilic Stippling . | Bone Marrow Examination . |
|---|---|---|---|---|---|---|---|
| Patient | Birth | 11.2-150 | 85 | ||||
| 3 mo | 6-151 | 14 | 64 | 84,000 | + | ||
| 7% | |||||||
| 2 yr | 9 | 50 | 500,000 | Hyperplasia | |||
| 15% | Sideroblasts-152: 46% | ||||||
| 6 yr | 9.2 | 59 | 285,000 | Hyperplasia | |||
| 8% | Sideroblasts-152: 30% | ||||||
| 19 yr | 11 | 60 | 169,000 | ||||
| 5% | |||||||
| Father | 50 yr | 14.2 | 85 | 25,000 | |||
| <0.6% | |||||||
| Mother | 49 yr | 13.9 | 80 | 37,000 | |||
| <0.6% | |||||||
| Sister | 22 yr | 13.8 | 78 | 32,000 | |||
| <0.6% |